We have located links that may give you full text access.
Coronary sinus Reducer non-responders: insights and perspectives.
EuroIntervention 2018 Februrary 21
AIMS: Coronary sinus (CS) Reducer is currently indicated for the treatment of refractory angina in patients unsuitable for coronary revascularization. A 15-30% of non-responders is a constant across literature. Alternative coronary venous drainage systems may be an important factor in determining if patients "respond" to this intervention. We propose a simple method to indirectly assess the presence of these alternative drainage systems and predict responsiveness to Reducer implantation.
METHODS AND RESULTS: We measure the differential pressure between baseline right atrial pressure and CS systolic pressure during balloon occlusion of the CS. In the majority of patients, most of the left coronary artery venous return is drained by the CS. These patients show a high differential pressure due effective interference of the Reducer with coronary venous return. Narrowing of the CS effectively reduces venous return establishing its anti-ischemic effects, with the most expected benefit from Reducer implantation. Patients with developed accessory venous drainage systems will show low differential pressures due to preserved alternative coronary venous outflow. In these patients, Reducer results in an insufficient pressure gradient across the CS and the anti-ischemic effects and benefits might be minimal.
CONCLUSIONS: We suggest a simple and effective diagnostic peri-procedural method that may provide additional information in predicting responders to Reducer therapy. We also explore CS hemodynamics in the setting of Reducer implantation, trying to give insights on the pathophysiology and biologic effect of this novel treatment. This may help clinicians to better select patients to undergo implantation, avoiding useless procedures and risks.
METHODS AND RESULTS: We measure the differential pressure between baseline right atrial pressure and CS systolic pressure during balloon occlusion of the CS. In the majority of patients, most of the left coronary artery venous return is drained by the CS. These patients show a high differential pressure due effective interference of the Reducer with coronary venous return. Narrowing of the CS effectively reduces venous return establishing its anti-ischemic effects, with the most expected benefit from Reducer implantation. Patients with developed accessory venous drainage systems will show low differential pressures due to preserved alternative coronary venous outflow. In these patients, Reducer results in an insufficient pressure gradient across the CS and the anti-ischemic effects and benefits might be minimal.
CONCLUSIONS: We suggest a simple and effective diagnostic peri-procedural method that may provide additional information in predicting responders to Reducer therapy. We also explore CS hemodynamics in the setting of Reducer implantation, trying to give insights on the pathophysiology and biologic effect of this novel treatment. This may help clinicians to better select patients to undergo implantation, avoiding useless procedures and risks.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app